False
Daniel Eisenman is Executive Director of Biosafety Services at Advarra where he directs the Institutional Biosafety Committee (IBC) and biosafety consulting services, helping researchers navigate regulatory requirements to ensure research is conducted safely and with minimal regulatory delay.
July 7, 2025
Ophthalmology is quietly becoming gene therapy’s next big frontier. Here’s how the science, the patients, and the regulations are aligning.
4 min read
Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.
False